Mirator 0.125 Tablet

产品概览

About Mirator 0.125 Tablet

Mirator 0.125 Tablet is a medication containing the active ingredient Pramipexole, classified as Dopamine agonist medication. Pramipexole, sold under the brand Mirapex among others, is a medication used to treat Parkinson's disease and restless legs syndrome. In Parkinson's disease it may be used alone or together with levodopa. It is taken by mouth. Pramipexole is a dopamine agonist of the non-ergoline class.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE Pramipexole dihydrochloride extended-release tablets are indicated for the treatment of Parkinson's disease
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Pramipexole, the active ingredient in Mirator 0.125 Tablet, belongs to the Dopamine agonist medication class. 1 INDICATIONS AND USAGE Pramipexole dihydrochloride extended-release tablets are indicated for the treatment of Parkinson's disease. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Mirator 0.125 Tablet. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Mirator 0.125 Tablet for extended periods without medical advice.